| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9309020 | Kidney International | 2005 | 8 Pages |
Abstract
Serum FGF-23 level was found to be the most useful factor in predicting future development of refractory secondary hyperparathyroidism in long-term dialysis patients with mild secondary hyperparathyroidism. The measurement of serum FGF-23 levels is a promising laboratory examination that can be applied in the clinical practice of uremic secondary hyperparathyroidism.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Shohei Nakanishi, Junichiro James Kazama, Tomoko Nii-Kono, Kentaro Omori, Takeyoshi Yamashita, Seiji Fukumoto, Fumitake Gejyo, Takashi Shigematsu, Masafumi Fukagawa,